col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


106 Results       Page 1

 [1] 
Elsevier: International Journal of Biological Macromolecules
  original article Date Title Authors   All Authors
1 [GO] 2023―Jun―03 Identification and characterization of 7-azaindole derivatives as inhibitors of the SARS-CoV-2 spike-hACE2 protein interaction Chaojie Wang, Fengming He, Ke Sun, Kaiqiang Guo, Sheng Lu, Tong Wu, et al. (+2)
2 [GO] 2023―Jun―01 How helpful were molecular dynamics simulations in shaping our understanding of SARS-CoV-2 spike protein dynamics? Jameel M. Abduljalil, Ahmed M. Elghareib, Ahmed Samir, Ahmed A. Ezat, Abdo A. Elfiky
3 [GO] 2023―May―17 A novel mutation-proof, next-generation vaccine to fight against upcoming SARS-CoV-2 variants and subvariants, designed through AI enabled approaches and tools, along with the machine learning based immune simulation: A vaccine breakthrough Manojit Bhattacharya, Abdulrahman Alshammari, Metab Alharbi, Kuldeep Dhama, Sang-Soo Lee, Chiranjib Chakraborty
4 [GO] 2023―May―11 Development of 2-chloroquinoline based heterocyclic frameworks as dual inhibitors of SARS-CoV-2 MPro and PLPro Bhavita Kattula, Bharati Reddi, Aruna Jangam, Lekhika Naik, Bala Manikanta Adimoolam, Suresh Vavilapalli, et al. (+5)
5 [GO] 2023―Apr―28 GMI, a fungal immunomodulatory protein, ameliorates SARS-CoV-2 envelope protein-induced inflammation in macrophages via inhibition of MAPK pathway Zhi-Hu Lin, Hsin Yeh, Hung-Chih Lo, Wei-Jyun Hua, Ming-Yang Ni, Li-Kai Wang, et al. (+3)
6 [GO] 2023―Apr―11 Molecular insights into the inhibition mechanism of harringtonine against essential proteins associated with SARS-CoV-2 entry Zhiwei Yang, Xinyue Fu, Yizhen Zhao, Xuhua Li, Jiangang Long, Lei Zhang
7 [GO] 2023―Mar―29 Preparation of a new monoclonal antibody against nucleocapsid protein of swine acute diarrhea syndrome coronavirus and identification of its linear antigenic epitope Xiao Cong, Lin Zhang, Haibo Zhu, Miaoli Wu, Yujun Zhu, Yuexiao Lian, et al. (+3)
8 [GO] 2023―Mar―28 Identification of RdRp inhibitors against SARS-CoV-2 through E-pharmacophore-based virtual screening, molecular docking and MD simulations approaches Hafiz Muzzammel Rehman, Muhammad Sajjad, Muhammad Akhtar Ali, Roquyya Gul, Muhammad Naveed, Muhammad Shahbaz Aslam, et al. (+7)
9 [GO] 2023―Mar―10 Protein-based nano-vaccines against SARS-CoV-2: Current design strategies and advances of candidate vaccines Dongliang Wang, Youqing Yuan, Bin Liu, Neal D. Epstein, Yi Yang
10 [GO] 2023―Feb―16 Bidirectional and persistent immunomodulation of Astragalus polysaccharide as an adjuvant of influenza and recombinant SARS-CoV-2 vaccine Danping Zhao, Xiuhong Chen, Linyuan Wang, Jianjun Zhang, Zhongpeng Zhao, Na Yue, et al. (+5)
11 [GO] 2023―Feb―03 Repurposing of US-FDA approved drugs against SARS-CoV-2 main protease (Mpro) by using STD-NMR spectroscopy, in silico studies and antiviral assays A. Mateen Khan, Saba Farooq, M. Iqbal Choudhary
12 [GO] 2023―Jan―20 Identification and characterization of aurintricarboxylic acid as a potential inhibitor of SARS-CoV-2 PLpro Rimanshee Arya, Vishal Prashar, Mukesh Kumar
13 [GO] 2023―Jan―09 Proteomic screening identifies RPLp2 as a specific regulator for the translation of coronavirus Hui-Jun Dong, Jing Wang, Xiu-Zhong Zhang, Cui-Cui Li, Jian-Feng Liu, Xiao-Jia Wang
14 [GO] 2022―Dec―30 Inhibitory effects of fucoidan from Laminaria japonica against some pathogenic bacteria and SARS-CoV-2 depend on its large molecular weight Xiaona Sun, Chunqing Ai, Chengrong Wen, Haoran Peng, Jingfeng Yang, Yuna Cui, Shuang Song
15 [GO] 2022―Dec―29 Therapeutic applications of nanobodies against SARS-CoV-2 and other viral infections: Current update Manojit Bhattacharya, Srijan Chatterjee, Sang-Soo Lee, Chiranjib Chakraborty
16 [GO] 2022―Dec―28 Major royal jelly proteins elicited suppression of SARS-CoV-2 entry and replication with halting lung injury Marwa M. Abu-Serie, Noha H. Habashy
17 [GO] 2022―Dec―14 SARS-CoV-2 RdRp uses NDPs as a substrate and is able to incorporate NHC into RNA from diphosphate form molnupiravir Maofeng Wang, Cancan Wu, Nan Liu, Fengyu Zhang, Hongjie Dong, Shuai Wang, et al. (+4)
18 [GO] 2022―Dec―14 Human antibody BD-218 has broad neutralizing activity against concerning variants of SARS-CoV-2 Bo Wang, Hua Xu, Zi-teng Liang, Tian-ning Zhao, Xin Zhang, Tian-bo Peng, et al. (+2)
19 [GO] 2022―Dec―14 Non-anticoagulant heparin derivatives for COVID-19 treatment Min Cao, Meng Qiao, Muhammad Sohail, Xing Zhang
20 [GO] 2022―Dec―12 Ginkgolic acids inhibit SARS-CoV-2 and its variants by blocking the spike protein/ACE2 interplay Yusen Xiang, Guanglei Zhai, Yaozong Li, Mengge Wang, Xixiang Chen, Ruyu Wang, et al. (+9)
21 [GO] 2022―Dec―05 Inhibitory activities of alginate phosphate and sulfate derivatives against SARS-CoV-2 in vitro Cheng Yang, Dan Li, Shixin Wang, Meijie Xu, Dingfu Wang, Xin Li, et al. (+2)
22 [GO] 2022―Nov―24 Structural evolution of Delta lineage of SARS-CoV-2 Mohammad Mahmoudi Gomari, Parastoo Tarighi, Edris Choupani, Shadi Abkhiz, Masoud Mohamadzadeh, Neda Rostami, et al. (+4)
23 [GO] 2022―Oct―08 Novel chimeric proteins mimicking SARS-CoV-2 spike epitopes with broad inhibitory activity Mario Cano-Muñoz, Daniel Polo-Megías, Ana Cámara-Artigas, José A. Gavira, María J. López-Rodríguez, Géraldine Laumond, et al. (+5)
24 [GO] 2022―Oct―05 The inhibitory activity of methoxyl flavonoids derived from Inula britannica flowers on SARS-CoV-2 3CLpro Jang Hoon Kim, Yea-In Park, Mok Hur, Woo Tae Park, Youn-Ho Moon, Sung-Cheol Koo, et al. (+2)
25 [GO] 2022―Sep―29 Agathisflavone, a natural biflavonoid that inhibits SARS-CoV-2 replication by targeting its proteases Otávio Augusto Chaves, Carlyle Ribeiro Lima, Natalia Fintelman-Rodrigues, Carolina Q. Sacramento, Caroline S. de Freitas, Leonardo Vazquez, et al. (+7)
26 [GO] 2022―Sep―26 Non-uniform aspects of the SARS-CoV-2 intraspecies evolution reopen question of its origin Sk. Sarif Hassan, Vaishnavi Kodakandla, Elrashdy M. Redwan, Kenneth Lundstrom, Pabitra Pal Choudhury, Ángel Serrano-Aroca, et al. (+15)
27 [GO] 2022―Sep―22 Non-coding RNA in SARS-CoV-2: Progress toward therapeutic significance Hanieh Shirvani, Hanieh Jafari, Sayyed Sajjad Moravveji, Fatemeh Abbasi Faranghizadeh, Mehrdad Talebi, Jalaledin Ghanavi, et al. (+5)
28 [GO] 2022―Sep―21 A SARS-CoV-2 vaccine based on conjugation of SARS-CoV-2 RBD with IC28 peptide and mannan Yunxia He, Weili Yu, Lijuan Shen, Wenying Yan, Lucheng Xiao, Jinming Qi, Tao Hu
29 [GO] 2022―Sep―18 Recent advances in applying G-quadruplex for SARS-CoV-2 targeting and diagnosis: A review Li-Yan Zhai, Ai-Min Su, Jing-Fan Liu, Jian-Jin Zhao, Xu-Guang Xi, Xi-Miao Hou
30 [GO] 2022―Sep―03 Unfolding of the SARS-CoV-2 spike protein through infrared and ultraviolet-C radiation based disinfection Nilkamal Mahanta, Swati Sharma, Laipubam Gayatri Sharma, Lalit M. Pandey, Uday Shanker Dixit
31 [GO] 2022―Jul―28 The SARS-CoV-2 targeted human RNA binding proteins network biology to investigate COVID-19 associated manifestations Kartikay Prasad, Pratibha Gour, Saurabh Raghuvanshi, Vijay Kumar
32 [GO] 2022―Jul―13 An integrated understanding of the evolutionary and structural features of the SARS-CoV-2 spike receptor binding domain (RBD) Dwipanjan Sanyal, Suharto Banerjee, Aritra Bej, Vaidehi Roy Chowdhury, Vladimir N. Uversky, Sourav Chowdhury, Krishnananda Chattopadhyay
33 [GO] 2022―Jun―08 Production and characterization of chimeric SARS-CoV-2 antigens based on the capsid protein of cowpea chlorotic mottle virus Claudia Almendárez-Rodriguez, Karla I. Solis-Andrade, Dania O. Govea-Alonso, Mauricio Comas-Garcia, Sergio Rosales-Mendoza
34 [GO] 2022―Apr―23 Designing and characterization of a SARS-CoV-2 immunogen with receptor binding motif grafted on a protein scaffold: An epitope-focused vaccine approach Ritika Khatri, Hilal Ahmad Parray, Ashish Kumar Agrahari, Zaigham Abbas Rizvi, Rachel Kaul, Sneha Raj, et al. (+5)
35 [GO] 2022―Apr―20 Isolation, characterization, and structure-based engineering of a neutralizing nanobody against SARS-CoV-2 Tingting Li, Bingjie Zhou, Yaning Li, Suqiong Huang, Zhipu Luo, Yuanze Zhou, et al. (+8)
36 [GO] 2022―Apr―19 Expression, purification, and biophysical characterization of recombinant MERS-CoV main (Mpro) protease Ghada Obeid Almutairi, Ajamaluddin Malik, Mona Alonazi, Javed Masood Khan, Abdullah S. Alhomida, Mohd Shahnawaz Khan, et al. (+3)
37 [GO] 2022―Mar―26 Interfering effects on the bioactivities of several key proteins of COVID-19/variants in diabetes by compounds from Lianqiao leaves: In silico and in vitro analyses Yishan Fu, Fei Pan, Lei Zhao, Shuai Zhao, Junjie Yi, Shengbao Cai
38 [GO] 2022―Mar―16 An insight to the therapeutic potential of algae-derived sulfated polysaccharides and polyunsaturated fatty acids: Focusing on the COVID-19 Kobra Ziyaei, Zahra Ataie, Majid Mokhtari, Kelvin Adrah, Mohammad Ali Daneshmehr
39 [GO] 2022―Mar―15 The spike glycoproteins of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape Pedro F.N. Souza, Felipe P. Mesquita, Jackson L. Amaral, Patrícia G.C. Landim, Karollyny R.P. Lima, Marília B. Costa, et al. (+8)
40 [GO] 2022―Feb―08 Human SARS-CoV-2 has evolved to increase U content and reduce genome size Yong Wang, Xin-Yu Chen, Liu Yang, Qin Yao, K.P. Chen
41 [GO] 2022―Jan―22 Three wave changes, new variant strains, and vaccination effect against COVID-19 pandemic Rehan M. El-Shabasy, Mohamed A. Nayel, Mohamed M. Taher, Rehab Abdelmonem, Kamel R. Shoueir, El Refaie Kenawy
42 [GO] 2022―Jan―22 Insights into the specificity for the interaction of the promiscuous SARS-CoV-2 nucleocapsid protein N-terminal domain with deoxyribonucleic acids Icaro Putinhon Caruso, Vitor dos Santos Almeida, Mariana Juliani do Amaral, Guilherme Caldas de Andrade, Gabriela Rocha de Araújo, Talita Stelling de Araújo, et al. (+21)
43 [GO] 2022―Jan―20 Review: A systematic review of virus-like particles of coronavirus: Assembly, generation, chimerism and their application in basic research and in the clinic Wan Lu, Zhuangzhuang Zhao, Yao-Wei Huang, Bin Wang
44 [GO] 2022―Jan―19 The Omicron (B.1.1.529) variant of SARS-CoV-2 binds to the hACE2 receptor more strongly and escapes the antibody response: Insights from structural and simulation data Abbas Khan, Hira Waris, Memoona Rafique, Muhammad Suleman, Anwar Mohammad, Syed Shujait Ali, et al. (+4)
45 [GO] 2022―Jan―17 Dimerization of SARS-CoV-2 nucleocapsid protein affects sensitivity of ELISA based diagnostics of COVID-19 Wajihul Hasan Khan, Nida Khan, Avinash Mishra, Surbhi Gupta, Vikrant Bansode, Deepa Mehta, et al. (+4)
46 [GO] 2021―Dec―28 Silymarin/curcumin loaded albumin nanoparticles coated by chitosan as muco-inhalable delivery system observing anti-inflammatory and anti COVID-19 characterizations in oleic acid triggered lung injury and in vitro COVID-19 experiment Nemany A.N. Hanafy, Maged A. El-Kemary
47 [GO] 2021―Dec―23 Is amyloid fibrillation related to 3D domain swapping for the C-terminal domain of SARS-CoV main protease? Zhiliang Yuan, Zhi Qu, Bo Duan, Tianyi Wang, Jiajun Xu, Bin Xia
48 [GO] 2021―Dec―04 Precise location of two novel linear epitopes on the receptor-binding domain surface of MERS-CoV spike protein recognized by two different monoclonal antibodies Pan Wang, Peiyang Ding, Qiang Wei, Aiping Wang, Hongliang Liu, Yunchao Liu, et al. (+5)
49 [GO] 2021―Dec―02 Emergence of unique SARS-CoV-2 ORF10 variants and their impact on protein structure and function Sk. Sarif Hassan, Kenneth Lundstrom, Ángel Serrano-Aroca, Parise Adadi, Alaa A.A. Aljabali, Elrashdy M. Redwan, et al. (+13)
50 [GO] 2021―Nov―24 Identifying potential novel insights for COVID-19 pathogenesis and therapeutics using an integrated bioinformatics analysis of host transcriptome Salem A. El-aarag, Amal Mahmoud, Mahmoud ElHefnawi
51 [GO] 2021―Nov―12 COVID-19 diagnosis: current and future techniques Aarjoo Sharma, Sanjeev Balda, Mansi Apreja, Kirti Kataria, Neena Capalash, Prince Sharma
52 [GO] 2021―Nov―11 Nanoparticular CpG-adjuvanted SARS-CoV-2 S1 protein elicits broadly neutralizing and Th1-biased immunoreactivity in mice Hui-Tsu Lin, Cheng-cheung Chen, Der-Jiang Chiao, Tein-Yao Chang, Xin-an Chen, Jenn-jong Young, Szu-Cheng Kuo
53 [GO] 2021―Nov―11 Structural and functional significance of the amino acid differences Val35Thr, Ser46Ala, Asn65Ser, and Ala94Ser in 3C-like proteinases from SARS-CoV-2 and SARS-CoV Alexander I. Denesyuk, Eugene A. Permyakov, Mark S. Johnson, Sergei E. Permyakov, Konstantin Denessiouk, Vladimir N. Uversky
54 [GO] 2021―Oct―31 Immunology and controlling of coronaviruses; the current enemy for humanity: A review Sarah I. Othman, Mohamed A. Nayel, Maha Abdulla Alwaele, Haifa Al Fassam, Gasem Mohammad Abu-Taweel, Naif Ghazi Altoom, et al. (+4)
55 [GO] 2021―Oct―29 SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfate Yi Zheng, Jinxiang Zhao, Jiaqi Li, Zhimou Guo, Jiajing Sheng, Xianlong Ye, et al. (+6)
56 [GO] 2021―Oct―28 SARS-COV-2, infection, transmission, transcription, translation, proteins, and treatment: A review Jahangir Emrani, Maryam Ahmed, Robert H. Newman, Misty D. Thomas, Nathan Mowa, Liesl JeffersFrancis, John C. Teleha
57 [GO] 2021―Oct―25 COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks Chandran Murugan, Sharmiladevi Ramamoorthy, Kuppuswamy Guruprasad, Rajesh Kumar Murugan, Yuvaraj Sivalingam, Anandhakumar Sundaramurthy
58 [GO] 2021―Oct―18 Review: Roles of human serum albumin in prediction, diagnoses and treatment of COVID-19 Gulam Rabbani, Saeyoung Nate Ahn
59 [GO] 2021―Oct―15 State-of-the-art review - A review on snake venom-derived antithrombotics: Potential therapeutics for COVID-19-associated thrombosis? Bhargab Kalita, Anthony J. Saviola, Stephen P. Samuel, Ashis K. Mukherjee
60 [GO] 2021―Sep―27 Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2 Sushil Pokhrel, Thamer A. Bouback, Abdus Samad, Suza Mohammad Nur, Rahat Alam, Md. Abdullah-Al-Mamun, et al. (+9)
61 [GO] 2021―Sep―24 Implications derived from S-protein variants of SARS-CoV-2 from six continents Sk. Sarif Hassan, Kenneth Lundstrom, Debmalya Barh, Raner Jośe Santana Silva, Bruno Silva Andrade, Vasco Azevedo, et al. (+18)
62 [GO] 2021―Sep―10 Genomics-guided targeting of stress granule proteins G3BP1/2 to inhibit SARS-CoV-2 propagation Nemat Ali, Kartikay Prasad, Abdullah F. AlAsmari, Metab Alharbi, Summya Rashid, Vijay Kumar
63 [GO] 2021―Sep―07 Mucosal IgA response elicited by intranasal immunization of Lactobacillus plantarum expressing surface-displayed RBD protein of SARS-CoV-2 Letian Li, Maopeng Wang, Jiayi Hao, Jicheng Han, Tingting Fu, Jieying Bai, et al. (+4)
64 [GO] 2021―Aug―18 Review on oxidative stress relation on COVID-19: Biomolecular and bioanalytical approach Mehrnaz Ebrahimi, Parviz Norouzi, Hossein Aazami, Ali Akbar Moosavi-Movahedi
65 [GO] 2021―Aug―14 SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review Hadis Fathizadeh, Saman Afshar, Mahmood Reza Masoudi, Pourya Gholizadeh, Mohammad Asgharzadeh, Khudaverdi Ganbarov, et al. (+3)
66 [GO] 2021―Aug―06 Repurposing clinically approved drugs for COVID-19 treatment targeting SARS-CoV-2 papain-like protease Yunxia Xu, Ke Chen, Juanli Pan, Yingshou Lei, Danting Zhang, Lipei Fang, et al. (+8)
67 [GO] 2021―Aug―06 The method utilized to purify the SARS-CoV-2 N protein can affect its molecular properties Aneta Tarczewska, Marta Kolonko-Adamska, Mirosław Zarębski, Jurek Dobrucki, Andrzej Ożyhar, Beata Greb-Markiewicz
68 [GO] 2021―Jul―30 Flavonoids in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CLpro: Inhibition potentials, covalent binding sites and inhibitory mechanisms Yuan Xiong, Guang-Hao Zhu, Ya-Ni Zhang, Qing Hu, Hao-Nan Wang, Hao-Nan Yu, et al. (+5)
69 [GO] 2021―Jul―27 Chitosan derivatives: A suggestive evaluation for novel inhibitor discovery against wild type and variants of SARS-CoV-2 virus Chandrima Modak, Anubhuti Jha, Nivya Sharma, Awanish Kumar
70 [GO] 2021―Jul―05 Treatment and prevention strategies for the COVID 19 pandemic: A review of immunotherapeutic approaches for neutralizing SARS-CoV-2 Pravas Kumar Baral, Jiang Yin, Michael N.G. James
71 [GO] 2021―Jun―07 A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2) Mao-Sen Zeng, Wen-Di Yu, Hui-Xian Wang, Jin-Yuan Liu, Pei-Ping Xu
72 [GO] 2021―May―26 Ethyl cellulose coated sustained release aspirin spherules for treating COVID-19: DOE led rapid optimization using arbitrary interface; applicable for emergency situations T. Sreejith, Kaladhar Kamalasanan, Ashna Moidu, Pooja Shyamsundar, Shanti V. Nair, Lakshmi J. Nair, P. Venkatesan
73 [GO] 2021―May―25 Chitosan, alginate, hyaluronic acid, gums, and β-glucan as potent adjuvants and vaccine delivery systems for viral threats including SARS-CoV-2: A review Shadpour Mallakpour, Elham Azadi, Chaudhery Mustansar Hussain
74 [GO] 2021―Apr―27 Chitin and chitosan as tools to combat COVID-19: A triple approach Mehrnoush Safarzadeh, Sahar Sadeghi, Mahdieh Azizi, Mohsen Rastegari-Pouyani, Ramin Pouriran, Mostafa Haji Molla Hoseini
75 [GO] 2021―Apr―26 Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy Yash Gupta, Dawid Maciorowski, Samantha E. Zak, Chandrashekhar V. Kulkarni, Andrew S. Herbert, Ravi Durvasula, et al. (+3)
76 [GO] 2021―Apr―24 Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CLpro Ruyu Wang, Qing Hu, Haonan Wang, Guanghao Zhu, Mengge Wang, Qian Zhang, et al. (+6)
77 [GO] 2021―Apr―21 Preparation of cellulose based wipes treated with antimicrobial and antiviral silver nanoparticles as novel effective high-performance coronavirus fighter Tamer Hamouda, Hassan M. Ibrahim, H.H. Kafafy, H.M. Mashaly, Nasser H. Mohamed, Nermin M. Aly
78 [GO] 2021―Apr―16 Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2 Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Vladimir N. Uversky, Alaa A.A. Aljabali, et al. (+19)
79 [GO] 2021―Mar―29 A review on antiviral and immunomodulatory polysaccharides from Indian medicinal plants, which may be beneficial to COVID-19 infected patients Ipsita Kumar Sen, Indranil Chakraborty, Amit Kumar Mandal, Sunil Kumar Bhanja, Sukesh Patra, Prasenjit Maity
80 [GO] 2021―Mar―23 A review on the interaction of nucleoside analogues with SARS-CoV-2 RNA dependent RNA polymerase Suliman Khan, Farnoosh Attar, Samir Haj Bloukh, Majid Sharifi, Faisal Nabi, Qian Bai, et al. (+2)
81 [GO] 2021―Mar―12 Exploitation of polyphenols and proteins using nanoencapsulation for anti-viral and brain boosting properties - Evoking a synergistic strategy to combat COVID-19 pandemic Nairah Noor, Adil Gani, Asir Gani, Asima Shah, Zanoor ul Ashraf
82 [GO] 2021―Mar―02 The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play Pedro F.N. Souza, Felipe P. Mesquita, Jackson L. Amaral, Patrícia G.C. Landim, Karollyny R.P. Lima, Marília B. Costa, et al. (+3)
83 [GO] 2021―Mar―01 SARS-CoV-2: Insights into its structural intricacies and functional aspects for drug and vaccine development Mandeep Kaur, Akanksha Sharma, Santosh Kumar, Gurpal Singh, Ravi P. Barnwal
84 [GO] 2021―Feb―17 Underscoring the immense potential of chitosan in fighting a wide spectrum of viruses: A plausible molecule against SARS-CoV-2? Nivya Sharma, Chandrima Modak, Pankaj Kumar Singh, Rahul Kumar, Dharmender Khatri, Shashi Bala Singh
85 [GO] 2021―Feb―11 COVID-19 as a worldwide selective event and bitter taste receptor polymorphisms: An ecological correlational study Shima Parsa, Vahid Mogharab, Mohsen Ebrahimi, Sayyed Reza Ahmadi, Behzad Shahi, Neema John Mehramiz, et al. (+7)
86 [GO] 2021―Feb―09 Potential drug targets of SARS-CoV-2: From genomics to therapeutics Anas Shamsi, Taj Mohammad, Saleha Anwar, Samreen Amani, Mohd Shahnawaz Khan, Fohad Mabood Husain, et al. (+3)
87 [GO] 2021―Feb―05 Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2 Ashuai Du, Rong Zheng, Cyrollah Disoma, Shiqin Li, Zongpeng Chen, Sijia Li, et al. (+18)
88 [GO] 2021―Feb―05 Targeting C-terminal Helical bundle of NCOVID19 Envelope (E) protein Shruti Mukherjee, Amaravadhi Harikishore, Anirban Bhunia
89 [GO] 2021―Jan―11 SARS-Cov-2 ORF3a: Mutability and function Martina Bianchi, Alessandra Borsetti, Massimo Ciccozzi, Stefano Pascarella
90 [GO] 2020―Dec―29 Development of new vaccine target against SARS-CoV2 using envelope (E) protein: An evolutionary, molecular modeling and docking based study Shreya Bhattacharya, Arundhati Banerjee, Sujay Ray
91 [GO] 2020―Dec―09 Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs Naveen Narayanan, Deepak T. Nair
92 [GO] 2020―Dec―06 Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches Vinit Raj, Jae Gyu Park, Kiu-Hyung Cho, Pilju Choi, Taejung Kim, Jungyeob Ham, Jintae Lee
93 [GO] 2020―Sep―28 Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials Fatemeh Oroojalian, Ali Haghbin, Behzad Baradaran, Nima Hemmat, Mohammad-Ali Shahbazi, Hossein Bannazadeh Baghi, et al. (+2)
94 [GO] 2020―Sep―24 Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13) Osman Mutluhan Ugurel, Ozal Mutlu, Emrah Sariyer, Sinem Kocer, Erennur Ugurel, Tugba Gul Inci, et al. (+2)
95 [GO] 2020―Sep―24 The structure-activity relationship of the interactions of SARS-CoV-2 spike glycoproteins with glucuronomannan and sulfated galactofucan from Saccharina japonica Weihua Jin, Wenjing Zhang, Dipanwita Mitra, Martin G. McCandless, Poonam Sharma, Ritesh Tandon, et al. (+2)
96 [GO] 2020―Sep―17 Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach Md. Sorwer Alam Parvez, Md. Adnan Karim, Mahmudul Hasan, Jomana Jaman, Ziaul Karim, Tohura Tahsin, et al. (+2)
97 [GO] 2020―Aug―24 Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2 Praveen Kumar Tripathi, Saurabh Upadhyay, Manju Singh, Siva Raghavendhar, Mohit Bhardwaj, Pradeep Sharma, Ashok Kumar Patel
98 [GO] 2020―Aug―01 Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening Olga Abian, David Ortega-Alarcon, Ana Jimenez-Alesanco, Laura Ceballos-Laita, Sonia Vega, Hugh T. Reyburn, et al. (+2)
99 [GO] 2020―Jul―18 A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor Pedro F.N. Souza, Francisco E.S. Lopes, Jackson L. Amaral, Cleverson D.T. Freitas, Jose T.A. Oliveira
100 [GO] 2020―Jul―15 Design of a Multi-epitope Vaccine against SARS-CoV-2 using Immunoinformatics approach Samira Sanami, Milad Zandi, Behzad Pourhossein, Gholam-Reza Mobini, Mohsen Safaei, Atena Abed, et al. (+3)
101 [GO] 2020―Jul―14 Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines Xiangyan Chen, Wenwei Han, Guixiang Wang, Xia Zhao
102 [GO] 2020―Jun―26 Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective Kartikay Prasad, Fatima Khatoon, Summya Rashid, Nemat Ali, Abdullah F. AlAsmari, Mohammad Z. Ahmed, et al. (+3)
103 [GO] 2020―Jun―26 Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach Ishtiaque Ahammad, Samia Sultana Lira
104 [GO] 2020―May―30 A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2 Maopeng Wang, Tingting Fu, Jiayi Hao, Letian Li, Mingyao Tian, Ningyi Jin, et al. (+2)
105 [GO] 2020―May―26 High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment Biswajit Naik, Nidhi Gupta, Rupal Ojha, Satyendra Singh, Vijay Kumar Prajapati, Dhaneswar Prusty
106 [GO] 2019―Dec―02 Construction and optimization of Lactobacillus plantarum expression system expressing glycoprotein 5 of porcine reproductive and respiratory syndrome virus Maopeng Wang, Shouwen Du, Wang Xu, Lina Song, Pengfei Hao, Ningyi Jin, et al. (+2)
 [1] 

106 Results       Page 1


[de][en]

Last change 2023―Apr―13 19:50:14 UTC

© Daten-Quadrat 2022       Done in 0.018 sec